CiteFacts · FDA Drug Shortages · FDA source
FDA shortage status: Isocarboxazid Tablet
FDA source answer
FDA currently lists this ingredient in shortage.
FDA source statuses: Current. First FDA posting: 2026-04-16. Latest FDA row update: 2026-08-06.
FDA lists 1 package records, with companies: Lifsa Drugs LLC. Package NDCs: 72336-032-01.
FDA shortage reason: Other
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Package NDC | Presentation | FDA availability field | FDA update |
|---|---|---|---|---|
| Lifsa Drugs LLC | 72336-032-01 | Marplan, Tablet, 10 mg, 100 count bottle (NDC 72336-032-01) | Limited Availability | 2026-08-06 |
Source facts
Grouped generic ingredient: Isocarboxazid Tablet · 1 package records
Therapeutic categories: Psychiatry
Dosage forms: Tablet
Routes: ORAL
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-10-06T18:55:41+00:00. Derived grouping is documented in this record's derivations.